FdaApplication
ANDA 210221
Identifiers
- fda_app_no: ANDA210221
Properties
| Property | Value |
|---|---|
| applicant_name | ALKEM LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2019-03-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEPHALEXIN | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION;ORAL |
| CEPHALEXIN | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION;ORAL |
2 products